# pathway_0014: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0014.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MTLQPTAADVGAMYDQYTSLLTDVMAGFIHVGYWEDPSSEETMEVATERMTREVGARLSSSAGQHILDVGCGTGKSAVQIANTHGVQITGITVSKSQIEEAQALYGSAVQAGQVSYQFANAMDLPFADASFDGAYAIESLVHMDDRRTALQNIARVLRPGSRLAIADLCLDAHCPNPEALARFHELFQVPPMSSGEELQELLRETGFRVLEFTDIRDNVRPVCKFLEKKALSLEGEVGEKLLEIATSMATLKELGYAFITAERI

[Multiple Choices]
A. L-methionine biosynthesis via de novo pathway. .
B. Antifungal biosynthesis. .
C. tRNA modification
D. capsule polysaccharide biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt record for a protein annotated as O-methyltransferase resE in the restricticin biosynthesis cluster, with the pathway listed as antifungal biosynthesis. The pathway annotation cites experimental evidence, though the underlying paper was not independently reviewed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may support an inference of a methyltransferase-like function, but that does not identify the specific biosynthetic pathway among the choices.


**Missing item-specific fact**

> The protein-specific association with restricticin/antifungal biosynthesis, established by annotation or experimental work, is absent from the input.


**Reason**

> Choosing B requires the specific pathway assignment for this protein; broad sequence-based functional inference does not distinguish it reliably from the alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched protein record explicitly assigns the pathway to antifungal biosynthesis; no competing option is supported by the supplied sequence alone.


### Important caveats

- The reviewer-only database evidence supports the key but was not available to the evaluated model.
- The pathway annotation cites a publication with experimental evidence, but the primary study was not independently validated here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may support an inference of a methyltransferase-like function, but that does not identify the specific biosynthetic pathway among the choices.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific association with restricticin/antifungal biosynthesis, established by annotation or experimental work, is absent from the input.",
    "reason": "Choosing B requires the specific pathway assignment for this protein; broad sequence-based functional inference does not distinguish it reliably from the alternatives."
  },
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record for a protein annotated as O-methyltransferase resE in the restricticin biosynthesis cluster, with the pathway listed as antifungal biosynthesis. The pathway annotation cites experimental evidence, though the underlying paper was not independently reviewed here."
  },
  "important_caveats": [
    "The reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The pathway annotation cites a publication with experimental evidence, but the primary study was not independently validated here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein record explicitly assigns the pathway to antifungal biosynthesis; no competing option is supported by the supplied sequence alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record for a protein annotated as O-methyltransferase resE in the restricticin biosynthesis cluster, with the pathway listed as antifungal biosynthesis. The pathway annotation cites experimental evidence, though the underlying paper was not independently reviewed here.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may support an inference of a methyltransferase-like function, but that does not identify the specific biosynthetic pathway among the choices.",
    "missing_item_specific_fact": "The protein-specific association with restricticin/antifungal biosynthesis, established by annotation or experimental work, is absent from the input.",
    "reason": "Choosing B requires the specific pathway assignment for this protein; broad sequence-based functional inference does not distinguish it reliably from the alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched protein record explicitly assigns the pathway to antifungal biosynthesis; no competing option is supported by the supplied sequence alone."
  },
  "important_caveats": [
    "The reviewer-only database evidence supports the key but was not available to the evaluated model.",
    "The pathway annotation cites a publication with experimental evidence, but the primary study was not independently validated here."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV1 (RESE_ASPSL) for this exact 264-aa sequence carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay/experimental), citing PubMed:39105744 (Lu et al., 2024, J. Agric. Food Chem.). The protein is annotated as 'O-methyltransferase resE' / 'Restricticin biosynthesis cluster protein E' from Aspergillus sclerotiorum. The sequence match is exact (SHA-256 identical). The expected answer B directly corresponds to the database pathway annotation supported by experimental evidence.

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could identify methyltransferase-like sequence motifs (e.g., the GCGTGK region suggestive of a SAM-binding Rossmann-like fold) and note the fungal origin, but the methyltransferase superfamily spans tRNA modification, secondary metabolite biosynthesis, lipid metabolism, and many other pathways. Distinguishing 'Antifungal biosynthesis' (a specific secondary metabolite cluster pathway) from 'tRNA modification' (C) or other methylation-dependent pathways requires knowing that this protein is resE in the restricticin biosynthetic gene cluster of A. sclerotiorum.


**Missing item-specific fact**

> The specific identity of this protein as resE, a member of the restricticin biosynthetic cluster, and the experimental demonstration (PubMed:39105744) that this cluster produces an antifungal/phytotoxic hybrid molecule. Without this protein-specific annotation or literature knowledge, the methyltransferase fold alone cannot distinguish antifungal secondary metabolite biosynthesis from tRNA modification or other methylation pathways.


**Reason**

> The sequence reveals a methyltransferase fold but does not encode pathway-specific information sufficient to select 'Antifungal biosynthesis' over 'tRNA modification' or other methyltransferase-associated pathways. Correct selection depends on recognizing this exact protein's role in the restricticin cluster, which is an item-specific database/literature fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> From sequence alone, the protein is identifiable as a SAM-dependent methyltransferase. Methyltransferases are prominent in tRNA modification pathways (option C), making C a superficially plausible alternative. Without knowing the restricticin cluster context, a model reasoning purely from sequence could not confidently eliminate C in favor of B. Option A (methionine biosynthesis) is less defensible because the sequence lacks hallmark features of Met biosynthesis enzymes (e.g., cobalamin-dependent methionine synthase domains, homoserine O-succinyltransferase motifs), and D (capsule polysaccharide biosynthesis) is poorly supported by methyltransferase fold features.


### Important caveats

- The UniProt pathway annotation uses ECO:0000269 (experimental/direct assay), lending stronger support than a purely computational annotation, but the underlying paper (Lu et al. 2024) describes a 'hybrid molecule with phytotoxic activity'—the categorization under 'Antifungal biosynthesis' reflects the biosynthetic cluster's function as characterized in that study.
- The entry was first public in February 2025; the author's data-construction snapshot is unknown. If the benchmark was constructed before this date, the annotation source may differ.
- The term 'Antifungal biosynthesis' is a UniProt-specific pathway category for secondary metabolite clusters with antifungal activity, not a standard KEGG/MetaCyc pathway name, which may affect general-knowledge reasoning.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could identify methyltransferase-like sequence motifs (e.g., the GCGTGK region suggestive of a SAM-binding Rossmann-like fold) and note the fungal origin, but the methyltransferase superfamily spans tRNA modification, secondary metabolite biosynthesis, lipid metabolism, and many other pathways. Distinguishing 'Antifungal biosynthesis' (a specific secondary metabolite cluster pathway) from 'tRNA modification' (C) or other methylation-dependent pathways requires knowing that this protein is resE in the restricticin biosynthetic gene cluster of A. sclerotiorum.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as resE, a member of the restricticin biosynthetic cluster, and the experimental demonstration (PubMed:39105744) that this cluster produces an antifungal/phytotoxic hybrid molecule. Without this protein-specific annotation or literature knowledge, the methyltransferase fold alone cannot distinguish antifungal secondary metabolite biosynthesis from tRNA modification or other methylation pathways.",
    "reason": "The sequence reveals a methyltransferase fold but does not encode pathway-specific information sufficient to select 'Antifungal biosynthesis' over 'tRNA modification' or other methyltransferase-associated pathways. Correct selection depends on recognizing this exact protein's role in the restricticin cluster, which is an item-specific database/literature fact."
  },
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV1 (RESE_ASPSL) for this exact 264-aa sequence carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay/experimental), citing PubMed:39105744 (Lu et al., 2024, J. Agric. Food Chem.). The protein is annotated as 'O-methyltransferase resE' / 'Restricticin biosynthesis cluster protein E' from Aspergillus sclerotiorum. The sequence match is exact (SHA-256 identical). The expected answer B directly corresponds to the database pathway annotation supported by experimental evidence."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses ECO:0000269 (experimental/direct assay), lending stronger support than a purely computational annotation, but the underlying paper (Lu et al. 2024) describes a 'hybrid molecule with phytotoxic activity'—the categorization under 'Antifungal biosynthesis' reflects the biosynthetic cluster's function as characterized in that study.",
    "The entry was first public in February 2025; the author's data-construction snapshot is unknown. If the benchmark was constructed before this date, the annotation source may differ.",
    "The term 'Antifungal biosynthesis' is a UniProt-specific pathway category for secondary metabolite clusters with antifungal activity, not a standard KEGG/MetaCyc pathway name, which may affect general-knowledge reasoning."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "From sequence alone, the protein is identifiable as a SAM-dependent methyltransferase. Methyltransferases are prominent in tRNA modification pathways (option C), making C a superficially plausible alternative. Without knowing the restricticin cluster context, a model reasoning purely from sequence could not confidently eliminate C in favor of B. Option A (methionine biosynthesis) is less defensible because the sequence lacks hallmark features of Met biosynthesis enzymes (e.g., cobalamin-dependent methionine synthase domains, homoserine O-succinyltransferase motifs), and D (capsule polysaccharide biosynthesis) is poorly supported by methyltransferase fold features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV1 (RESE_ASPSL) for this exact 264-aa sequence carries a PATHWAY annotation of 'Antifungal biosynthesis' with evidence code ECO:0000269 (direct assay/experimental), citing PubMed:39105744 (Lu et al., 2024, J. Agric. Food Chem.). The protein is annotated as 'O-methyltransferase resE' / 'Restricticin biosynthesis cluster protein E' from Aspergillus sclerotiorum. The sequence match is exact (SHA-256 identical). The expected answer B directly corresponds to the database pathway annotation supported by experimental evidence.",
    "evidence_ids": ["C1", "C3", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could identify methyltransferase-like sequence motifs (e.g., the GCGTGK region suggestive of a SAM-binding Rossmann-like fold) and note the fungal origin, but the methyltransferase superfamily spans tRNA modification, secondary metabolite biosynthesis, lipid metabolism, and many other pathways. Distinguishing 'Antifungal biosynthesis' (a specific secondary metabolite cluster pathway) from 'tRNA modification' (C) or other methylation-dependent pathways requires knowing that this protein is resE in the restricticin biosynthetic gene cluster of A. sclerotiorum.",
    "missing_item_specific_fact": "The specific identity of this protein as resE, a member of the restricticin biosynthetic cluster, and the experimental demonstration (PubMed:39105744) that this cluster produces an antifungal/phytotoxic hybrid molecule. Without this protein-specific annotation or literature knowledge, the methyltransferase fold alone cannot distinguish antifungal secondary metabolite biosynthesis from tRNA modification or other methylation pathways.",
    "reason": "The sequence reveals a methyltransferase fold but does not encode pathway-specific information sufficient to select 'Antifungal biosynthesis' over 'tRNA modification' or other methyltransferase-associated pathways. Correct selection depends on recognizing this exact protein's role in the restricticin cluster, which is an item-specific database/literature fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "From sequence alone, the protein is identifiable as a SAM-dependent methyltransferase. Methyltransferases are prominent in tRNA modification pathways (option C), making C a superficially plausible alternative. Without knowing the restricticin cluster context, a model reasoning purely from sequence could not confidently eliminate C in favor of B. Option A (methionine biosynthesis) is less defensible because the sequence lacks hallmark features of Met biosynthesis enzymes (e.g., cobalamin-dependent methionine synthase domains, homoserine O-succinyltransferase motifs), and D (capsule polysaccharide biosynthesis) is poorly supported by methyltransferase fold features."
  },
  "important_caveats": [
    "The UniProt pathway annotation uses ECO:0000269 (experimental/direct assay), lending stronger support than a purely computational annotation, but the underlying paper (Lu et al. 2024) describes a 'hybrid molecule with phytotoxic activity'—the categorization under 'Antifungal biosynthesis' reflects the biosynthetic cluster's function as characterized in that study.",
    "The entry was first public in February 2025; the author's data-construction snapshot is unknown. If the benchmark was constructed before this date, the annotation source may differ.",
    "The term 'Antifungal biosynthesis' is a UniProt-specific pathway category for secondary metabolite clusters with antifungal activity, not a standard KEGG/MetaCyc pathway name, which may affect general-knowledge reasoning."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The matched UniProt record assigns this protein to antifungal biosynthesis and cites evidence code ECO:0000269, indicating experimental evidence. This supports choice B, though the excerpt does not independently describe the experiment.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a motif compatible with a SAM-dependent methyltransferase, which could suggest methylation chemistry. But that general enzyme-level clue does not meaningfully distinguish antifungal biosynthesis from other options that can also involve methyltransferases.


**Missing item-specific fact**

> The protein's assignment to a particular biosynthetic pathway, such as its role in an antifungal-producing pathway or its association with that pathway's biosynthetic machinery.


**Reason**

> The sequence may support a broad enzyme-class inference, but the choices ask for pathway membership. Distinguishing the offered pathways requires specific functional or pathway-context information not evident from the sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The available sequence does not establish multiple pathway choices as correct; rather, it provides too little pathway-specific evidence to distinguish them.


### Important caveats

- The pathway assignment is supported by the cited database annotation, not by a detailed experimental account in the supplied excerpts.
- The exact sequence match is established in reviewer-only source-applicability metadata, which was not part of the original input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a motif compatible with a SAM-dependent methyltransferase, which could suggest methylation chemistry. But that general enzyme-level clue does not meaningfully distinguish antifungal biosynthesis from other options that can also involve methyltransferases.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's assignment to a particular biosynthetic pathway, such as its role in an antifungal-producing pathway or its association with that pathway's biosynthetic machinery.",
    "reason": "The sequence may support a broad enzyme-class inference, but the choices ask for pathway membership. Distinguishing the offered pathways requires specific functional or pathway-context information not evident from the sequence alone."
  },
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The matched UniProt record assigns this protein to antifungal biosynthesis and cites evidence code ECO:0000269, indicating experimental evidence. This supports choice B, though the excerpt does not independently describe the experiment."
  },
  "important_caveats": [
    "The pathway assignment is supported by the cited database annotation, not by a detailed experimental account in the supplied excerpts.",
    "The exact sequence match is established in reviewer-only source-applicability metadata, which was not part of the original input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The available sequence does not establish multiple pathway choices as correct; rather, it provides too little pathway-specific evidence to distinguish them."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched UniProt record assigns this protein to antifungal biosynthesis and cites evidence code ECO:0000269, indicating experimental evidence. This supports choice B, though the excerpt does not independently describe the experiment.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a motif compatible with a SAM-dependent methyltransferase, which could suggest methylation chemistry. But that general enzyme-level clue does not meaningfully distinguish antifungal biosynthesis from other options that can also involve methyltransferases.",
    "missing_item_specific_fact": "The protein's assignment to a particular biosynthetic pathway, such as its role in an antifungal-producing pathway or its association with that pathway's biosynthetic machinery.",
    "reason": "The sequence may support a broad enzyme-class inference, but the choices ask for pathway membership. Distinguishing the offered pathways requires specific functional or pathway-context information not evident from the sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The available sequence does not establish multiple pathway choices as correct; rather, it provides too little pathway-specific evidence to distinguish them."
  },
  "important_caveats": [
    "The pathway assignment is supported by the cited database annotation, not by a detailed experimental account in the supplied excerpts.",
    "The exact sequence match is established in reviewer-only source-applicability metadata, which was not part of the original input."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV1 (sequence matched exactly) annotates this protein as O-methyltransferase resE / Restricticin biosynthesis cluster protein E from Aspergillus sclerotiorum, with pathway 'Antifungal biosynthesis' supported by experimental evidence (ECO:0000269, PubMed 39105744, 2024). The sequence in the question matches the canonical entry sequence (264 aa, SHA256 identical). The author key B aligns with the database annotation.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a clear Rossmann-fold SAM-binding motif (GCGTGK at positions ~85-90) and an overall architecture (~264 aa) consistent with a small Class I SAM-dependent O-methyltransferase. Transferable knowledge allows elimination of the other choices: (A) L-methionine biosynthesis methyltransferases (e.g., MetH cobalamin-dependent or MetE cobalamin-independent) are large multi-domain enzymes (>500 aa) with distinct architectures; (C) tRNA-modification methyltransferases typically possess additional RNA-recognition domains (e.g., PUA, KOW, or catalytic domains of specific tRNA-modifying families) not present here; (D) capsule polysaccharide biosynthesis involves glycosyltransferases (GT-A/GT-B folds), not SAM-dependent methyltransferases. The small size, standalone methyltransferase fold, and absence of primary-metabolism or RNA-binding domains are most consistent with a tailoring enzyme in a fungal secondary-metabolite gene cluster, which among the offered choices maps to 'Antifungal biosynthesis' (B). Fungal secondary metabolite clusters (NRPS/PKS pathways) routinely encode small O-methyltransferases as tailoring enzymes, a well-documented pattern across many fungal species.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can recognize the methyltransferase fold, note the small standalone size inconsistent with primary metabolic methyltransferases or tRNA-modifying enzymes, and exclude glycosyltransferases for polysaccharide synthesis. By elimination among the four offered options, the secondary-metabolite biosynthesis pathway (B) is the only category consistent with a small fungal O-methyltransferase. The specific 'antifungal' label is narrow, but it is the sole secondary-metabolite option presented, making the elimination argument sufficient to select B.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options span distinct biochemical categories (primary amino acid metabolism, secondary metabolite biosynthesis, RNA modification, polysaccharide synthesis). The methyltransferase fold and small size clearly exclude A, C, and D, leaving B as the only category compatible with a small fungal tailoring methyltransferase. No genuine ambiguity among the offered choices.


### Important caveats

- The specific designation 'antifungal' (as opposed to antibacterial, antitumor, or other secondary metabolite pathways) cannot be positively identified from sequence alone; it is selected by elimination since B is the only secondary-metabolite option offered.
- The UniProt annotation carries experimental evidence (ECO:0000269) from a single 2024 study (PubMed 39105744); the protein's role in antifungal compound (restricticin) biosynthesis was established by heterologous expression and genome mining in that study.
- The organism identity (Aspergillus sclerotiorum) is not provided to the model; fungal origin is inferred from sequence composition and the context of the question, but this is a weaker inference than explicit organism data.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold SAM-binding motif (GCGTGK at positions ~85-90) and an overall architecture (~264 aa) consistent with a small Class I SAM-dependent O-methyltransferase. Transferable knowledge allows elimination of the other choices: (A) L-methionine biosynthesis methyltransferases (e.g., MetH cobalamin-dependent or MetE cobalamin-independent) are large multi-domain enzymes (>500 aa) with distinct architectures; (C) tRNA-modification methyltransferases typically possess additional RNA-recognition domains (e.g., PUA, KOW, or catalytic domains of specific tRNA-modifying families) not present here; (D) capsule polysaccharide biosynthesis involves glycosyltransferases (GT-A/GT-B folds), not SAM-dependent methyltransferases. The small size, standalone methyltransferase fold, and absence of primary-metabolism or RNA-binding domains are most consistent with a tailoring enzyme in a fungal secondary-metabolite gene cluster, which among the offered choices maps to 'Antifungal biosynthesis' (B). Fungal secondary metabolite clusters (NRPS/PKS pathways) routinely encode small O-methyltransferases as tailoring enzymes, a well-documented pattern across many fungal species.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can recognize the methyltransferase fold, note the small standalone size inconsistent with primary metabolic methyltransferases or tRNA-modifying enzymes, and exclude glycosyltransferases for polysaccharide synthesis. By elimination among the four offered options, the secondary-metabolite biosynthesis pathway (B) is the only category consistent with a small fungal O-methyltransferase. The specific 'antifungal' label is narrow, but it is the sole secondary-metabolite option presented, making the elimination argument sufficient to select B."
  },
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV1 (sequence matched exactly) annotates this protein as O-methyltransferase resE / Restricticin biosynthesis cluster protein E from Aspergillus sclerotiorum, with pathway 'Antifungal biosynthesis' supported by experimental evidence (ECO:0000269, PubMed 39105744, 2024). The sequence in the question matches the canonical entry sequence (264 aa, SHA256 identical). The author key B aligns with the database annotation."
  },
  "important_caveats": [
    "The specific designation 'antifungal' (as opposed to antibacterial, antitumor, or other secondary metabolite pathways) cannot be positively identified from sequence alone; it is selected by elimination since B is the only secondary-metabolite option offered.",
    "The UniProt annotation carries experimental evidence (ECO:0000269) from a single 2024 study (PubMed 39105744); the protein's role in antifungal compound (restricticin) biosynthesis was established by heterologous expression and genome mining in that study.",
    "The organism identity (Aspergillus sclerotiorum) is not provided to the model; fungal origin is inferred from sequence composition and the context of the question, but this is a weaker inference than explicit organism data."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span distinct biochemical categories (primary amino acid metabolism, secondary metabolite biosynthesis, RNA modification, polysaccharide synthesis). The methyltransferase fold and small size clearly exclude A, C, and D, leaving B as the only category compatible with a small fungal tailoring methyltransferase. No genuine ambiguity among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV1 (sequence matched exactly) annotates this protein as O-methyltransferase resE / Restricticin biosynthesis cluster protein E from Aspergillus sclerotiorum, with pathway 'Antifungal biosynthesis' supported by experimental evidence (ECO:0000269, PubMed 39105744, 2024). The sequence in the question matches the canonical entry sequence (264 aa, SHA256 identical). The author key B aligns with the database annotation.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold SAM-binding motif (GCGTGK at positions ~85-90) and an overall architecture (~264 aa) consistent with a small Class I SAM-dependent O-methyltransferase. Transferable knowledge allows elimination of the other choices: (A) L-methionine biosynthesis methyltransferases (e.g., MetH cobalamin-dependent or MetE cobalamin-independent) are large multi-domain enzymes (>500 aa) with distinct architectures; (C) tRNA-modification methyltransferases typically possess additional RNA-recognition domains (e.g., PUA, KOW, or catalytic domains of specific tRNA-modifying families) not present here; (D) capsule polysaccharide biosynthesis involves glycosyltransferases (GT-A/GT-B folds), not SAM-dependent methyltransferases. The small size, standalone methyltransferase fold, and absence of primary-metabolism or RNA-binding domains are most consistent with a tailoring enzyme in a fungal secondary-metabolite gene cluster, which among the offered choices maps to 'Antifungal biosynthesis' (B). Fungal secondary metabolite clusters (NRPS/PKS pathways) routinely encode small O-methyltransferases as tailoring enzymes, a well-documented pattern across many fungal species.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can recognize the methyltransferase fold, note the small standalone size inconsistent with primary metabolic methyltransferases or tRNA-modifying enzymes, and exclude glycosyltransferases for polysaccharide synthesis. By elimination among the four offered options, the secondary-metabolite biosynthesis pathway (B) is the only category consistent with a small fungal O-methyltransferase. The specific 'antifungal' label is narrow, but it is the sole secondary-metabolite option presented, making the elimination argument sufficient to select B."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span distinct biochemical categories (primary amino acid metabolism, secondary metabolite biosynthesis, RNA modification, polysaccharide synthesis). The methyltransferase fold and small size clearly exclude A, C, and D, leaving B as the only category compatible with a small fungal tailoring methyltransferase. No genuine ambiguity among the offered choices."
  },
  "important_caveats": [
    "The specific designation 'antifungal' (as opposed to antibacterial, antitumor, or other secondary metabolite pathways) cannot be positively identified from sequence alone; it is selected by elimination since B is the only secondary-metabolite option offered.",
    "The UniProt annotation carries experimental evidence (ECO:0000269) from a single 2024 study (PubMed 39105744); the protein's role in antifungal compound (restricticin) biosynthesis was established by heterologous expression and genome mining in that study.",
    "The organism identity (Aspergillus sclerotiorum) is not provided to the model; fungal origin is inferred from sequence composition and the context of the question, but this is a weaker inference than explicit organism data."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV1",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "9d95ee40b689b53793e1326b5c6bfc2a9c1aa1eebfb365d9fc2d0250df01e630",
  "benchmark_sequence_length": 264,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "current_source_sequence_sha256": "9d95ee40b689b53793e1326b5c6bfc2a9c1aa1eebfb365d9fc2d0250df01e630",
  "current_source_sequence_length": 264,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 4,
  "selected_historical_version": {
    "accession": "P0DXV1",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESE_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "cd2e82952af8d3844a3a9c286440d6c646ca7af305696f06813c85a3b4406cf2",
  "selected_historical_source_sequence_sha256": "9d95ee40b689b53793e1326b5c6bfc2a9c1aa1eebfb365d9fc2d0250df01e630",
  "selected_historical_source_sequence_length": 264,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV1\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein E\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"O-methyltransferase resE\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV1.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV1.json",
  "source_sha256": "28f2208ebdc3c58c28d8c0bd9978354bcb775822363a3845e9d7dffaefd695cd",
  "retrieved_utc": "2026-11-02T04:29:42.952467+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4",
  "source_sha256": "cd2e82952af8d3844a3a9c286440d6c646ca7af305696f06813c85a3b4406cf2",
  "retrieved_utc": "2026-11-02T04:29:45.445708+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   RESE_ASPSL              Reviewed;         264 AA.\nAC   P0DXV1;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=O-methyltransferase resE {ECO:0000303|PubMed:39105744};\nDE            EC=2.1.1.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein E {ECO:0000303|PubMed:39105744};\nGN   Name=resE {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4",
  "source_sha256": "cd2e82952af8d3844a3a9c286440d6c646ca7af305696f06813c85a3b4406cf2",
  "retrieved_utc": "2026-11-02T04:29:45.445708+00:00",
  "source_locator": "lines 15-21",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV1?format=txt&versions=4",
  "source_sha256": "cd2e82952af8d3844a3a9c286440d6c646ca7af305696f06813c85a3b4406cf2",
  "retrieved_utc": "2026-11-02T04:29:45.445708+00:00",
  "source_locator": "lines 48-48",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 14. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
